Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
  • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
  • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
  • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/445—Non condensed piperidines, e.g. piperocaine
  • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
  • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/06—Antiasthmatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/08—Bronchodilators
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
  • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
  • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
  • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Applications Claiming Priority (2)

Publications (1)

Family

ID=50884281

Family Applications (1)

Country Status (32)

Families Citing this family (4)

Family Cites Families (8)

• 2015
  • 2015-05-28 US US14/723,964 patent/US9763924B2/en active Active
  • 2015-06-03 PT PT15731261T patent/PT3152201T/en unknown
  • 2015-06-03 MX MX2016015958A patent/MX2016015958A/en active IP Right Grant
  • 2015-06-03 EA EA201692227A patent/EA032761B1/en not_active IP Right Cessation
  • 2015-06-03 MA MA39947A patent/MA39947B1/en unknown
  • 2015-06-03 WO PCT/EP2015/062417 patent/WO2015185649A1/en active Application Filing
  • 2015-06-03 SI SI201530392T patent/SI3152201T1/en unknown
  • 2015-06-03 ES ES15731261.2T patent/ES2688826T3/en active Active
  • 2015-06-03 PL PL15731261T patent/PL3152201T3/en unknown
  • 2015-06-03 GE GEAP201514338A patent/GEP20186922B/en unknown
  • 2015-06-03 EP EP15731261.2A patent/EP3152201B1/en active Active
  • 2015-06-03 CA CA2953198A patent/CA2953198C/en active Active
  • 2015-06-03 DK DK15731261.2T patent/DK3152201T3/en active
  • 2015-06-03 LT LTEP15731261.2T patent/LT3152201T/en unknown
  • 2015-06-03 RS RS20181192A patent/RS57787B1/en unknown
  • 2015-06-03 KR KR1020167032346A patent/KR102420323B1/en active IP Right Grant
  • 2015-06-03 AU AU2015270539A patent/AU2015270539B2/en not_active Expired - Fee Related
  • 2015-06-03 PE PE2016002520A patent/PE20161557A1/en unknown
  • 2015-06-03 CN CN201580029748.7A patent/CN106459020B/en active Active
  • 2015-06-03 BR BR112016026725-7A patent/BR112016026725B1/en active Search and Examination
  • 2015-06-03 HU HUE15731261A patent/HUE042119T2/en unknown
  • 2015-06-03 SG SG11201610132RA patent/SG11201610132RA/en unknown
  • 2015-06-03 TN TN2016000546A patent/TN2016000546A1/en unknown
  • 2015-06-03 JP JP2016571037A patent/JP2017516824A/en not_active Withdrawn
  • 2015-06-04 TW TW104118107A patent/TW201625600A/en unknown
  • 2015-06-04 AR ARP150101772A patent/AR100732A1/en unknown
• 2016
  • 2016-11-09 PH PH12016502221A patent/PH12016502221A1/en unknown
  • 2016-12-01 IL IL249325A patent/IL249325B/en not_active IP Right Cessation
  • 2016-12-02 CL CL2016003117A patent/CL2016003117A1/en unknown
  • 2016-12-02 ZA ZA2016/08331A patent/ZA201608331B/en unknown
• 2017
  • 2017-08-10 US US15/673,710 patent/US10117860B2/en active Active
• 2018
  • 2018-09-24 CY CY181100984T patent/CY1120698T1/en unknown
  • 2018-11-23 HR HRP20181967TT patent/HRP20181967T1/en unknown

Also Published As

Similar Documents